Outcomes following Pediatric Auditory Brainstem Implant Surgery: Early Experiences in a North American Center

Sidharth V. Puram, Samuel R. Barber, Elliott D. Kozin, Parth Shah, Aaron Remenschneider, Barbara S. Herrmann, Ann Christine Duhaime, Fred G. Barker, Daniel J. Lee

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

There are no approved Food and Drug Administration indications for pediatric auditory brainstem implant (ABI) surgery in the United States. Our prospective case series aims to determine the safety and feasibility of ABI surgery in pediatric patients <5 years old with congenital deafness at a tertiary North American center. The inclusion criterion was pre- or postlinguistic deafness in children not eligible for cochlear implantation. Seventeen candidates were evaluated (mean ± SD: age, 2.52 ± 0.39 years). Four patients underwent ABI surgery (age, 19.2 ± 3.43 months), including 4 primary procedures and 1 revision for device failure. Spontaneous device failure occurred in another subject postoperatively. No major/minor complications occurred, including cerebrospinal fluid leak, facial nerve injury, hematoma, and nonauditory stimulation. All subjects detected sound with environmental awareness, and several demonstrated babbling and mimicry. Poor durability of older implants underscores need for updated technology.

Original languageEnglish
Pages (from-to)133-138
Number of pages6
JournalOtolaryngology - Head and Neck Surgery (United States)
Volume155
Issue number1
DOIs
StatePublished - Jul 1 2016

Keywords

  • ABI
  • auditory brainstem implant
  • clinical trial
  • deafness
  • hearing loss
  • nonneurofibromatosis type II
  • pediatric

Fingerprint

Dive into the research topics of 'Outcomes following Pediatric Auditory Brainstem Implant Surgery: Early Experiences in a North American Center'. Together they form a unique fingerprint.

Cite this